Delivery Order SPE2DR25D2006-SPE2DR26F56FL
- Not listed
- The Defense Logistics Agency awarded a competitively bid delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 2 mg tablets (60-count units) with a ceiling value of $4,845.92. This non-set-aside order was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and utilizes firm fixed pricing. AmerisourceBergen will perform the work from its corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Risperdal 3 mg tablets. The $10,105.80 contract has an ultimate completion date of August 12, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of medical commodities to federal agencies, including the military. This order is part of AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperidone 0.5 mg tablets (60-count) with a firm fixed price ceiling value of $6,580.29. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 4, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Risperidone 2 mg tablets in quantities of 60 units at a firm fixed price of $2,213.75. The contract carries an ultimate completion date of July 17, 2025, and represents a non-set-aside, competitively awarded procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,290.00 to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg, a pharmaceutical product used in treating psychiatric conditions. This firm fixed-price delivery order, issued on November 5, 2025, with an ultimate completion date of November 6, 2025, represents a routine pharmaceutical procurement under a non-set-aside competitive award. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to provide 4,558,617 units of 0.25 mg Risperidone tablets, a prescription medication. The fixed-price contract, valued at $30,000.17, has a completion date of September 28, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Risperidone 0.5 mg tablets in quantities of 60 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,682.34 and represents a firm fixed-price delivery order with an ultimate completion date of November 19, 2025. The pharmaceutical product will be sourced from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a $1,110.06 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperidone 0.25 mg, with an ultimate completion date of October 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,029.30 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Risperidone 3 mg tablets in quantities of 60 units. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is expected to be completed by August 18, 2025, with performance taking place at the vendor's corporate office in...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Risperdal 1 mg tablets, a mental health medication, for $1,023.97. The contract has a period of performance ending on June 30, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026,...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F56FLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Risperdal 4 mg tablets (60-count units) with a firm fixed price ceiling value of $2,526.04. The order was competitively awarded without set-aside designation and is scheduled for completion by November 21, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a critical vendor in the federal medical supply chain, AmerisourceBergen fulfills diverse pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver both brand-name and generic medications, vaccines, and specialized medical supplies through competitive procurement processes. This particular delivery order reflects the company's ongoing role in supporting military and veteran healthcare logistics through the DLA's pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/20/25 |